https://www.marketscreener.com/quote/stock/PRIVETERRA-ACQUISITION-CO-119661014/news/AEON-Biopharma-Receives-Notice-of-Allowance-from-USPTO-for-a-Patent-Covering-Use-of-Botulinum-Toxins-44689290/?utm_source=telegram&utm_medium=social&utm_campaign=share